Manufacturing

Articles

The companies have entered into a manufacturing agreement for the production of Phase III clinical trial material.

Caladrius Biosciences, Cognate BioServices in Clinical Manufacturing Pact

Agnes Shanley is senior editor of Pharmaceutical Technology.

Personalized medicine and direct-to-patient trial models have made the difficult even more challenging.

Orchestrating Success in Clinical Trial Manufacturing

Barrett Fallentine is director of Product and Process Development, Pharmatech Associates, bfallentine@pai-qbd.com. 

Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.

Mind the Gap: Tech Transfer from Early Stage Cell Culture to Phase I Clinical Manufacture

The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.

QPS Expands US-Based Phase I Clinical Trial Capabilities

The new center will integrate biologics drug discovery, development, clinical manufacturing, and commercial manufacturing.

WuXi Biologics Begins Construction of Major Biologics Center in China

The expanded Frederick, MD, site will help meet global demand for diagnostic instruments and cell and gene therapies for clinical trials.

Thermo Fisher Opens Newly Expanded Facility in Maryland

The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.

Symbiosis Secures FDA Viral Vector Process Approval

PCI Pharma Services and CSP Technologies will partner on protective packaging solutions for clinical trials and stability testing.

PCI Pharma, CSP to Partner on Packaging Solutions

ICS distribution center will serve manufacturers of specialty medications, biosimilars, and cell and gene therapies.

ICS Opens Logistics Distribution Center in Ohio

The pharmaceutical, clinical, and bioanalytical contract solutions provider has implemented advanced techniques for the collection and use of peripheral blood mononuclear cells (PBMCs) for early-phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.

Clinical Trial Materials